{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/65736d39d32e730012c98919/65848508e11a76001692644c?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Launch of Tome Biosciences, AI scientist, mRNA vaccines ","description":"<p>Episode 2 (December 22, 2023): Interview with President and CEO of Tome Biosciences, Rahul Kakkar; intelligent lab partner using LLMs; AI for antimicrobials; mRNA vaccine production in Africa; Moderna’s positive cancer vaccine data.</p><p>Listed below are key references to the <em>GEN</em> stories, media and other items discussed in this episode of <em>Touching Base</em>:</p><p><br></p><ul><li><a href=\"https://www.genengnews.com/topics/genome-editing/the-next-chapter-in-genome-editing-tome-emerges-from-stealth-with-213m/\" rel=\"noopener noreferrer\" target=\"_blank\">The Next Chapter in Genome Editing? Tome Emerges from Stealth with $213M</a> By Alex Philippidis, GEN, December 19, 2023.</li><li><a href=\"https://www.genengnews.com/topics/artificial-intelligence/artificial-intelligence-based-lab-partner-designs-runs-experiments-in-the-lab/\" rel=\"noopener noreferrer\" target=\"_blank\">Artificial Intelligence-Based Lab Partner Designs, Runs Experiments in the Lab</a> GEN, December 20, 2023.</li><li><a href=\"https://www.genengnews.com/topics/infectious-diseases/biontech-advances-plans-for-mrna-vaccine-production-in-africa-by-2025/\" rel=\"noopener noreferrer\" target=\"_blank\">BioNTech Advances Plans for mRNA Vaccine Production in Africa by 2025</a> GEN, December 19, 2023.</li><li><a href=\"https://www.genengnews.com/topics/artificial-intelligence/explainable-ai-directs-small-molecule-structural-class-drug-discovery/\" rel=\"noopener noreferrer\" target=\"_blank\">Explainable AI Directs Small Molecule Structural Class Drug Discovery</a> By Jonathan Grinstein, GEN, December 20, 2023.</li><li><a href=\"https://www.genengnews.com/topics/cancer/stockwatch-positive-cancer-vaccine-data-wows-moderna-investors/\" rel=\"noopener noreferrer\" target=\"_blank\">StockWatch: Positive Cancer Vaccine Data Wows Moderna Investors</a> By Alex Philippidis, GEN Edge, December 18, 2023.</li></ul><p><br></p>","author_name":"Genetic Engineering & Biotechnology News (GEN)"}